Evidence map›Paper›PMID 42303707›Full record

ArticleScientific reports2026

Non-invasive opportunistic screening for diabetes mellitus: an interpretable stacking ensemble framework.

Lin Zhang, Junming Xu, Weigang Wang, Rui Chang, Linghua Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lin ZhangZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, 310003, China.
Junming XuDepartment of Statistics and Data Science, Zhejiang Gongshang University, Hangzhou, 310018, China. xujm_zjgsu@163.com.
Weigang WangDepartment of Statistics and Data Science, Zhejiang Gongshang University, Hangzhou, 310018, China. wangweigang@zjgsu.edu.cn.
Rui ChangJining No.1 People's Hospital, Jining, 272100, China.
Linghua WangZhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, 310003, China. wlh12263579@163.com.

Funding

National Natural Science Foundation of China 12371150
6 · The paper itself

Abstract

Opportunistic screening for type 2 diabetes offers a potentially accessible approach to preliminary case detection without relying on invasive testing. In this study, we developed a heterogeneous Stacking ensemble model (Task C) using exclusively non-invasive demographic, lifestyle, medical-history, and symptom-based features. The model prioritized sensitivity, achieving a Recall of 0.9267, while showing modest discriminative performance (AUC = 0.5515), low specificity (0.1106), and moderate probability calibration (Brier Score = 0.2482). Targeted simulation analyses revealed that adjusting the top three modifiable behavioral factors captured approximately 85.5% of the reduction in model-estimated screening probability observed under the all-six-factor adjustment. Individual-level case simulation illustrated a stepwise reduction in model-estimated screening probability under increasingly comprehensive hypothetical adjustments. Decision curve analysis suggested potential screening utility mainly within the lower-threshold range. These findings suggest that the proposed ensemble may serve as a technically feasible and interpretable tool for preliminary non-invasive diabetes case-finding, while providing hypothesis-generating insights into modifiable factors for future validation.

Indexed as

Diabetes Mellitus, Type 2Mass ScreeningComputer SimulationEnsemble LearningHumansDiabetes mellitusIn Silico simulationInterpretable stackingOpportunistic screeningSMOTENC

Identifiers

PMID42303707
PMCPMC13538591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.